Matthew Harbaugh - Mallinckrodt Plc CFO and Sr. VP

MNKDelisted Stock  USD 0.34  0.00  0.00%   

CFO

Mr. Matthew K. Harbaugh is Executive Vice President of Mallinckrodt Public Limited Company. He has executive responsibility for finance, procurement and information technology. Mr. Harbaugh previously served as Vice President, Finance of Covidiens Pharmaceuticals business, a position he held from July 2008 until June 2013, when Mallinckrodt became an independent public company. He also served as Interim President of Covidiens Pharmaceuticals business from November 2010 to January 2012. Mr. Harbaugh joined Covidiens Pharmaceuticals business in August 2007 as its Vice President and Controller, Global Finance for the Global Medical Imaging business since 2018.
Age 46
Tenure 6 years
Phone353 1 696 0000
Webhttps://www.mallinckrodt.com
Harbaugh was a Lead Finance Executive with Cerberus Capital Management, L.P., a New Yorkbased private equity firm, from April 2007 until August 2007. Prior to that Mr. Harbaugh worked nearly ten years for Monsanto, where he held several positions, including corporate finance director, investor relations, and finance director/chief financial officer for Monsanto Argentine/Chilean and Canadian operations via two expatriate assignments.

Mallinckrodt Plc Management Efficiency

Mallinckrodt Plc's management efficiency ratios could be used to measure how well Mallinckrodt Plc manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 3.07 B in debt with debt to equity (D/E) ratio of 1.44, which is OK given its current industry classification. Mallinckrodt Plc has a current ratio of 2.92, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Mallinckrodt Plc until it has trouble settling it off, either with new capital or with free cash flow. So, Mallinckrodt Plc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mallinckrodt Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mallinckrodt to invest in growth at high rates of return. When we think about Mallinckrodt Plc's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CFO Age

Norman FujitakiWestern Metals
52
Mallinckrodt plc develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. The company was founded in 1867 and is based in Dublin, Ireland. Mallinckrodt Plc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 2778 people. Mallinckrodt Plc (MNK) is traded on NYSE MKT Exchange in USA and employs 2,673 people.

Management Performance

Mallinckrodt Plc Leadership Team

Elected by the shareholders, the Mallinckrodt Plc's board of directors comprises two types of representatives: Mallinckrodt Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mallinckrodt. The board's role is to monitor Mallinckrodt Plc's management team and ensure that shareholders' interests are well served. Mallinckrodt Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mallinckrodt Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gary Phillips, Executive Vice President and Chief Strategy Officer
Steven Romano, Executive Vice President and Chief Scientific Officer
Mark Casey, Executive Vice President and Chief Legal Officer
JoAnn Reed, Independent Director
Virgil Thompson, Independent Director
Lisa French, Ex Officer
Stephen Welch, Ex Generics
Henriette Nielsen, Ex Officer
Steven MD, Ex Officer
Diane Gulyas, Independent Director
Joseph Zaccagnino, Independent Director
Paul Carter, Independent Director
David Carlucci, Independent Director
CPA CPA, Global Officer
George Kegler, CFO, Executive Vice President
Frank Scholz, Executive Vice President and Chief Operations and Digital Innovation Officer
David Norton, Independent Director
Hugh ONeill, Executive Vice President and President, Autoimmune and Rare Diseases
Martin Carroll, Independent Director
Steve Romano, Senior Vice President Chief Scientific Officer
Sigurdur Olafsson, Pres CEO
Mark Trudeau, CEO and President Director and Member of Portfolio Committee
Kneeland Youngblood, Independent Director
Bryan Reasons, Chief Financial Officer, Executive Vice President
J Carroll, Independent Director
Meredith Fischer, Senior Vice President - Communications and Public Affairs
Kassie Harrold, Ex Officer
Jason Goodson, Exec Devel
Terrance Carlson, Senior Vice President and General Counsel - Interim
Ian Watkins, Chief Human Resource Officer, Executive Vice President
Dagmar RosaBjorkeson, Chief Strategy and Corporate Development Officer
Melvin Booth, Independent Chairman of the Board
Raymond Furey, Senior Vice President Chief Compliance Officer
Angus Russell, Independent Non-Executive Chairman of the Board
Ronald Lloyd, Executive Vice President and President - Hospital Therapies
Karen Sheehy, Chief Compliance Officer
Matthew Harbaugh, CFO and Sr. VP
MichaelBryant Hicks, General Counsel
Carlos Paya, Independent Director
Anne Whitaker, Independent Director
Mark Tyndall, Chief VP

Mallinckrodt Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mallinckrodt Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mallinckrodt Plc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mallinckrodt Plc's short interest history, or implied volatility extrapolated from Mallinckrodt Plc options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Consideration for investing in Mallinckrodt Stock

If you are still planning to invest in Mallinckrodt Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mallinckrodt Plc's history and understand the potential risks before investing.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk